WallStreetZenWallStreetZen

NASDAQ: SRPT
Sarepta Therapeutics Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for SRPT

Based on 8 analysts offering 12 month price targets for Sarepta Therapeutics Inc.
Min Forecast
$101.00-17.86%
Avg Forecast
$144.88+17.82%
Max Forecast
$190.00+54.52%

Should I buy or sell SRPT stock?

Based on 8 analysts offering ratings for Sarepta Therapeutics Inc.
Buy
Strong Buy
2 analysts 25%
Buy
4 analysts 50%
Hold
2 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SRPT stock forecasts and price targets.

SRPT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Goldman Sachs
Top 6%
95
Strong BuyMaintains$171.00+39.07%2022-11-03
RBC Capital
Top 3%
98
BuyMaintains$190.00+54.52%2022-11-03
Credit Suisse
Bottom 9%
9
HoldMaintains$101.00-17.86%2022-11-03
Needham
Bottom 7%
7
BuyMaintains$158.00+28.50%2022-11-03
SVB Leerink
Bottom 4%
4
BuyMaintains$145.00+17.92%2022-10-17
Morgan Stanley
Bottom 3%
3
HoldMaintains$141.00+14.67%2022-10-13
Cantor Fitzgerald
Top 6%
95
Strong BuyMaintains$128.00+4.10%2022-06-24
Anonymous
Goldman Sachs
Strong BuyMaintains$155.00+26.06%2022-05-24
Oppenheimer
Bottom 12%
12
BuyUpgrades$125.00+1.66%2021-12-09

1 of 1

Forecast return on equity

Is SRPT forecast to generate an efficient return?
Company
133.86%
Industry
14.42%
Market
62.81%
SRPT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SRPT forecast to generate an efficient return on assets?
Company
18.27%
Industry
13.43%
SRPT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SRPT earnings per share forecast

What is SRPT's earnings per share in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
-$6.89
Avg 2 year Forecast
-$4.03
Avg 3 year Forecast
$6.47

SRPT revenue forecast

What is SRPT's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$921.8M+5.22%
Avg 2 year Forecast
$1.2B+40.69%
Avg 3 year Forecast
$2.0B+125%
SRPT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SRPT revenue growth forecast

How is SRPT forecast to perform vs Biotechnology companies and vs the US market?
Company
29.18%
Industry
25.1%
Market
6.74%
SRPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SRPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SRPT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SRPT$122.96$144.88+17.82%Buy
NBIX$124.00$122.77-1.00%Buy
JAZZ$150.97$199.00+31.81%Buy
UTHR$273.72$272.22-0.55%Buy
TECH$82.60$461.00+458.11%Buy

Sarepta Therapeutics Stock Forecast FAQ

Is Sarepta Therapeutics Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: SRPT) stock is to Buy SRPT stock.

Out of 8 analysts, 2 (25%) are recommending SRPT as a Strong Buy, 4 (50%) are recommending SRPT as a Buy, 2 (25%) are recommending SRPT as a Hold, 0 (0%) are recommending SRPT as a Sell, and 0 (0%) are recommending SRPT as a Strong Sell.

If you're new to stock investing, here's how to buy Sarepta Therapeutics stock.

What is SRPT's earnings growth forecast for 2022-2024?

(NASDAQ: SRPT) Sarepta Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.88%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.01%.

Sarepta Therapeutics's earnings in 2022 is -$716,225,000.On average, 5 Wall Street analysts forecast SRPT's earnings for 2022 to be -$604,821,949, with the lowest SRPT earnings forecast at -$751,418,851, and the highest SRPT earnings forecast at -$501,238,509. On average, 6 Wall Street analysts forecast SRPT's earnings for 2023 to be -$353,763,781, with the lowest SRPT earnings forecast at -$459,980,698, and the highest SRPT earnings forecast at $12,289,561.

In 2024, SRPT is forecast to generate $567,953,267 in earnings, with the lowest earnings forecast at -$4,389,129 and the highest earnings forecast at $1,449,290,330.

What is SRPT's revenue growth forecast for 2022-2024?

(NASDAQ: SRPT) Sarepta Therapeutics's forecast annual revenue growth rate of 29.18% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 25.1%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 6.74%.

Sarepta Therapeutics's revenue in 2022 is $876,047,000.On average, 6 Wall Street analysts forecast SRPT's revenue for 2022 to be $80,918,241,905, with the lowest SRPT revenue forecast at $79,925,157,622, and the highest SRPT revenue forecast at $81,953,812,954. On average, 6 Wall Street analysts forecast SRPT's revenue for 2023 to be $108,189,391,443, with the lowest SRPT revenue forecast at $93,459,475,190, and the highest SRPT revenue forecast at $133,462,872,899.

In 2024, SRPT is forecast to generate $173,028,937,814 in revenue, with the lowest revenue forecast at $114,047,122,739 and the highest revenue forecast at $272,389,333,328.

What is SRPT's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: SRPT) forecast ROA is 18.27%, which is higher than the forecast US Biotechnology industry average of 13.43%.

What is SRPT's Price Target?

According to 8 Wall Street analysts that have issued a 1 year SRPT price target, the average SRPT price target is $144.88, with the highest SRPT stock price forecast at $190.00 and the lowest SRPT stock price forecast at $101.00.

On average, Wall Street analysts predict that Sarepta Therapeutics's share price could reach $144.88 by Nov 3, 2023. The average Sarepta Therapeutics stock price prediction forecasts a potential upside of 17.82% from the current SRPT share price of $122.96.

What is SRPT's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: SRPT) Sarepta Therapeutics's current Earnings Per Share (EPS) is -$8.22. On average, analysts forecast that SRPT's EPS will be -$6.89 for 2022, with the lowest EPS forecast at -$8.56, and the highest EPS forecast at -$5.71. On average, analysts forecast that SRPT's EPS will be -$4.03 for 2023, with the lowest EPS forecast at -$5.24, and the highest EPS forecast at $0.14. In 2024, SRPT's EPS is forecast to hit $6.47 (min: -$0.05, max: $16.51).

What is SRPT's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: SRPT) forecast ROE is 133.86%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.